🇺🇸 Azacitidine Injection in United States

46 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Neutropenia — 7 reports (15.22%)
  2. Pancytopenia — 7 reports (15.22%)
  3. Respiratory Failure — 5 reports (10.87%)
  4. Confusional State — 4 reports (8.7%)
  5. Febrile Neutropenia — 4 reports (8.7%)
  6. Injection Site Erythema — 4 reports (8.7%)
  7. Neutropenic Sepsis — 4 reports (8.7%)
  8. Pleural Effusion — 4 reports (8.7%)
  9. Septic Shock — 4 reports (8.7%)
  10. Acute Febrile Neutrophilic Dermatosis — 3 reports (6.52%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Azacitidine Injection approved in United States?

Azacitidine Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Azacitidine Injection in United States?

Ascentage Pharma Group Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.